CD133 cells have stronger proliferation, invasion, metastasis and self-renewal capabilities, and have CSCs biological properties, which are key factors leading to recurrence, metastasis, and resistance to radiotherapy and chemotherapy in laryngeal cancer (Silva Galbiatti-Dias et al., 2018) (Figure 3a ∼ c). Here, PROM1 is linked to laryngeal carcinoma.